Practice Milestones

 

  • 12/31/18 – Recognized as the number one enrolling site for the DREAM-HF study.
  • 10/3/17 – First patient treated in the CONTROL HTN-2 study using the new innovative ROX Coupler Device.
  • 11/17/15 – First patient treated in Alabama for the CALM-First in Human protocol, baroreceptor modulation using the MobiusHD for subjects with resistant hypertension.
  • 4/7/15 – First patient treated in Alabama for the REINFORCE: REDUCE-HTN study, renal denervation using the Vessix Reduce™ Catheter and Vessix™ Generator for the treatment of hypertension.
  • 4/17/12 – First in human delivery of JVS-100 in the world, administered by direct intramuscular injection to adults with critical limb ischemia.
  • 12/7/2011 – First patient enrolled in the HTN-3 renal denervation study in Alabama for patients with resistant hypertension.
  • 3/23/10 – First in human endomyocardial injection, worldwide, of the angiogenic agent ACRX-100 with a percutaneous catheter.
  • 2/7/08 – First patient treated in Alabama via percutaneous intramyocardial stem cell transplant to the heart.
  • 1/24/08 – First patient treated in Alabama via implantation of stem cells for peripheral artery disease.
  • 11/23/04 – First intramyocardial delivery of hepatocyte growth factor with percutaneous catheter in the world (CORAUTUS).
  • 11/10/04 – First patient treated in Alabama via intramyocardial delivery of angiogenic agent with percutaneous catheter.
  • 4/29/03 – First administration of hepatocyte growth factor for peripheral artery disease in the United States.
  • 6/15/02 – First published therapeutic angiogenesis trial with positive results proving concept (TRAFFIC).
  • 8/15/01 – First gene therapy trial for peripheral artery disease performed in Alabama (RAVE).
  • 9/22/99 – First therapeutic angiogenesis trial performed in Alabama (TRAFFIC).
Proud member of the
We are currently experiencing issues with our after hours telephone system. If you need to reach us after hours, please call our answering service directly at 205-930-4461
+